BioMarin Pharmaceutical, Inc. (BMRN)
57.18
-1.26
(-2.16%)
USD |
NASDAQ |
Oct 02, 16:00
57.30
+0.12
(+0.21%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap : 11.07B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.07B |
| October 01, 2026 | 11.31B |
| September 30, 2026 | 11.61B |
| September 29, 2026 | 11.59B |
| September 28, 2026 | 11.51B |
| September 25, 2026 | 11.66B |
| September 24, 2026 | 11.87B |
| September 23, 2026 | 12.04B |
| September 22, 2026 | 12.26B |
| September 21, 2026 | 12.40B |
| September 18, 2026 | 12.37B |
| September 17, 2026 | 12.60B |
| September 16, 2026 | 12.53B |
| September 15, 2026 | 12.47B |
| September 14, 2026 | 12.85B |
| September 11, 2026 | 12.71B |
| September 10, 2026 | 12.68B |
| September 09, 2026 | 12.47B |
| September 08, 2026 | 12.51B |
| September 04, 2026 | 12.88B |
| September 03, 2026 | 12.86B |
| September 02, 2026 | 12.96B |
| September 01, 2026 | 12.55B |
| August 31, 2026 | 12.62B |
| August 28, 2026 | 12.51B |
| Date | Value |
|---|---|
| August 27, 2026 | 12.64B |
| August 26, 2026 | 12.70B |
| August 25, 2026 | 12.80B |
| August 24, 2026 | 12.59B |
| August 21, 2026 | 12.91B |
| August 20, 2026 | 13.10B |
| August 19, 2026 | 13.42B |
| August 18, 2026 | 12.96B |
| August 17, 2026 | 12.90B |
| August 14, 2026 | 13.04B |
| August 13, 2026 | 13.26B |
| August 12, 2026 | 13.59B |
| August 11, 2026 | 13.46B |
| August 10, 2026 | 13.33B |
| August 07, 2026 | 12.35B |
| August 06, 2026 | 11.89B |
| August 05, 2026 | 11.59B |
| August 04, 2026 | 11.75B |
| August 03, 2026 | 11.60B |
| July 31, 2026 | 11.60B |
| July 30, 2026 | 11.71B |
| July 29, 2026 | 11.86B |
| July 28, 2026 | 12.00B |
| July 27, 2026 | 11.65B |
| July 24, 2026 | 11.47B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Ascendis Pharma A/S | 14.96B |
| BridgeBio Pharma, Inc. | 13.13B |
| Incyte Corp. | 23.17B |
Market Cap Related Metrics
| PE Ratio | 154.17 |
| PS Ratio | 3.211 |
| Price to Book Value | 1.750 |
| Price to Free Cash Flow | 15.31 |
| Price | 57.18 |
| Earnings Yield | 0.65% |
| Operating PE Ratio | 17.35 |
| Normalized PE Ratio | 29.03 |